We find that maintenance of fetal-specific gene expression programs accounts for a large proportion (~40%) of the unique molecular profile of MLL-AF4 infant-ALL, suggesting that it is the fetal target cells in which the translocation arises that provide the permissive cellular context for aggressive infant-ALL. Here, KMT2A is linked to acute lymphoblastic leukemia.